Abstract
The purpose of this chapter is to discuss the historical perspectives, current state of the literature, and suggested new strategies for the identification of the opioid receptors involved in the control of neuroendocrine function. As will become apparent, there is a vast body of data on the neuroendocrine effects of various opiate agonists and antagonists, and the involvement of endogenous opioid peptides (EOPs*) in neuroendocrine function, but an extensive literature review suggests that we know only one factor for certain: Exogenous and endogenous opioids exert pronounced effects on endocrine function, and EOPs may be intimately involved in the physiological regulation of endocrine function. However, we cannot definitively draw conclusions as to which EOPs are involved in these effects or the opioid receptor subtype that mediates these effects. The reasons for this conclusion will be discussed fully below, but it seems clear that, after intense study for nearly two decades, we can only conclude that compounds with some selectivity for x and.t receptors influence neuroendocrine function. Also, we are still uncertain whether one or both receptors are involved
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
T. J. Cicero (1980) Effects of exogenous and endogenous opiates on the hypothalamic-pituitary-gonadal axis in the male rat.Fed. Proc.39, 2551–2554.
T. J. Cicero (1984) Opioid-mediated control of LH in the male: physiological implications, inOpioid Modulation of Endocrine FunctionG. Delitala, M. Motta, and M. Serio, eds. Raven, New York, pp. 211–222.
Cicero, T. J. (1987) Basic endocrine pharmacology of opioid agonists and antagonists, inPharmacology and Clinical Uses of Inhibitors of Hormone Secretion and Action. G. J. A. Furr and A. E. Wakeling, eds. Bailliere Tindall, London, pp. 518–537.
S. P. Kalra and P. S. Kalra (1983) Neural regulation of LH secretion in the rat.Endocr. Rev.4, 311.
S. P. Kalra and C. A. Leadem (1984) Control of luteinizing hormone secretion by endocrine opioid peptides, inOpioid Modulation of Endocrine Function.M. Morro and M. Serio, eds. Raven, New York, p. 171.
C. M. Kuhn and R. T. Windh (1992) Endocrine action of opiates, inBiochemistry of Substance Abuse.CRC, Boca Raton, FL, in press.
C. B. Pert and S. H. Snyder (1973) Opiate receptor: demonstration in nervous tissue.Science179, 1011–1914.
E. J. Simon, J. M. Hiller, and I. Edelmand (1973) Stereospecific binding of the potent narcotic analagesic3H-etorphine to rat brain homogenates.Proc. Natl. Acad. Sci. USA70, 1947–1949.
L. Terenius (1973) Characterization of the “receptor” for narcotic analgesics in synaptic plasma membrane fractions from rat brain.Acta Pharmacol. Toxicol.33, 377–384.
W. R. Martin (1988) The evolution of concepts of opioid receptors, inThe Opiate Receptors. G. W. Pasternak, ed. Humana, Clifton, NJ, pp. 3–22.
G. W. Pasternak (1988) Early studies of opioid binding, inThe Opiate Receptors. G. W. Pasternak, ed. Humana, Clifton, NJ, pp. 75–94.
J. Hughes, T. W. Smith, H. W. Kosterlitz, L. A. Fothergill, B. A. Morgan, and H. R. Morris (1975) Identification of two related pentapeptides from the brain with potent opiate agonist activity.Nature258, 577–579.
C. H. Li and D. Chung (1976) Isolation and structure of an untriakontapeptide with opiate activity from camel pituitary glands.Proc. Natl. Acad. Sci. USA73, 1145–1148.
A. Goldstein, S. Tachibona, L. I. Lowney, M. Hunkapillar, and L. Hood (1979) Dynorphin-(1–13): an extraordinary potent opioid peptide.Proc. Natl. Acad. Sci. USA76, 6666–6670.
SI. James, C. Chavkin, and A. Goldstein (1982) Selectivity of dynorphin for tc opioid receptors.Life Sci.31, 1331–1334.
O. F. X. Almeida, K. E. Nikolarakis, G. E. Webley, and A. Herz (1988) Opioid components of the clockwork that governs luteinizing hormone and prolactin release in male rats.FASEB J.2, 2875–2877.
L. Grandison and A. Guidotti (1977) Regulation of prolactin release by endogenous opiates.Nature270, 357–359.
RD. A. Van Vugt, J. F. Bruni, and J. Meiters (1977) Naloxone inhibition of stress-induced increase in prolactin secretion.Life Sci.22, 85–90.
S. H. Shin (1978) Blockage of the ether-induced surge of prolactin by naloxone in male rats.J. Endocr.79, 397–398.
V. V. Ragavan and A. G. Frantz (1981) Opioid regulation of prolactin secretion: evidence for a specific role of ß-endorphin.Endocrinology109, 1769–1771.
F. Petraglia, W. Vale, and C. Rivier (1987) Beta-endorphin and dynorphin participate in the stress-induced release of prolactin in the rat.Neuroendocrinology45, 338–342.
G. Hulse, G. Coleman, J. Nicholas, and K. Greenwood (1982) Reversal of the antiovulatory action of stress in rats by prior administration of naloxone hydrochloride.J. Reprod. Fertil.66, 451.
K. P. Brisky, K. Quigley, and J. Meites (1984) Endogenous opiate involvement in acute and chronic stress-induced changes in plasma LII concentrations in the male rat.Life Sci.34, 2485.
F. Petraglia, W. Vale, andC.Rivier (1986) Opioids act centrally to modulate stress-induced decrease in luteinizing hormone in the rat.Endocrinology119, 2445–2450.
SG. K. Hulse and G. J. Coleman (1983) The role of endogenous opioids in the blockade of reproductive function in the rat following exposure to acute stress.Pharmacol. Biochem. Behay.19, 795.
K. A. Roth, E. Weber, and J. D. Barchas (1983) Immunoreactive dynorphin-(1–8) and corticotropin-releasing factor in subpopulations of hypothalamic neurons.Science219, 189.
D. J. S. Sirinathsinghji, L. H. Rees, J. Rivier, and W. Vale (1983) Corticotropinreleasing factor is a potent inhibitor of sexual receptivity in the female rat.Nature305, 15.
C. Rivier and W. Vale (1984) Influence of corticotropin-releasing factor on reproductive functions in the rat.Endocrinology114, 914.
R. B. Goodman, B. A. Adler, and G. W. Pasternak (1988) Regional distribution of opioid receptors, inThe Opiate ReceptorsG. W. Pasternak, ed. Humana, Clifton, NJ, pp. 197–230.
Y. Itzhak (1988) Multiple opioid binding sites, inThe Opiate Receptors. G. W. Pasternak, ed. Humana, Clifton, NJ, pp. 95–142.
L. A. Bero and C. M. Kuhn (1987) Differential ontogeny of opioid, dopaminergic and serotonergic regulation of prolactin secretion.J. Pharmacol. Exp. Ther.240, 825–830.
L. A. Bero, S. N. Lurie, and C. M. Kuhn (1987) Early ontogeny of x-opioid receptor regulation of prolactin secretion in the rat.Dey. Brain Res.37, 189–196.
D. M. Ignar, R. T. Windh, and C. M. Kuhn (1992) Chronic administration of U50,448H fails to produce hypothalamo-pituitary-adrenal axis tolerance in neonatal rats.Neoropharmacol.31, 143–148.
J. I. Koenig, M. A. Mayfield, S. M. McCann, and L. Krulich (1984) Differential role of the opioid mu and delta receptors in the activation of prolactin (PRL) and growth hormone (GH) secretion by morphine in the malerat. Life Sci.34, 1829–1837.
A. E. Panerai, F. Petraglia, P. Sacerdote, and A. R. Genazzani (1985) Mainly mu-opiate receptors are involved in luteinizing hormone and prolactin secretion.Endocrinology117, 1096–1099.
R. Pechnick, R. George, and R. E. Poland (1985) Identification of multiple opiate receptors through neuroendocrine responses. I. Effects of agonists.J. Pharmacol. Exp. Ther.232, 163–169.
R. Pechnick, R. George, and R. E. Poland (1985) Identification of multiple opiate receptors through neuroendocrine responses. II. Antagonism of mu, kappa and sigma agonists by naloxone and WIN 44,441–3.J. Pharm. Exp. Ther.232, 170–177.
W. T. Adamson, R. T. Windh, S. Blackford, and C. Kuhn (1991) Ontogeny of mu and kappa opiate receptor control of the HPA axis in rats.Endocrinology129, 959–964.
T. J. Cicero, P. F. Schmoeker, E. R. Meyer, B. T. Miller, R. D. Bell, S. M. Cytron, and C. C. Brown (1986) Ontogeny of the opioid-mediated control of reproductive endocrinology in the male and female rat.J. Phamacol. Exp. Ther.236, 627–633.
T. J. Cicero, E. R. Meyer, B. T. Miller, and R. D. Bell (1988) Age-related differences in the sensitivity of serum luteinizing hormone to protypic mu, kappa and delta opiate agonists and antagonists.J. Pharmacol. Exp. Ther.246, 14–20.
T. J. Cicero, L. O’Connor, B. Nock, and M. L. Adams (1989) Age-related differences in the sensitivity to opiate-induced perturbations in reproductive endocrinology in the developing and adult male rat.J. Pharmacol. Exp. Ther.248, 256–261.
T. J. Cicero, M. L. Adams, A. Giordano, B. T. Miller, L. O’Connor, and B. Nock (1991) Influence of morphine exposure during adolescence on the sexual maturation of male rats and the development of their offspring. J.Pharmacol. Exp. Ther.256, 1086–1093.
JR. Schulz, A. Wilhelm, K. M. Pirke, G. Gramsch, and A. Herz (1981) Beta-endorphin and dynorphin control serum luteinizing hormone level in immature female rats.Nature294, 757.
M. L. Adams and T. J. Cicero (1989) The ontogeny of immunoreactive 0-endorphin and 0-lipotropin in the rat testis.Life Sci.63, 159–166.
R. M. Sharpe (1989) Endocrinology and paracrinology of the testis, in Physiology andToxicology of Male Reproduction.J.C. Lamb and P. M. D. Foster, eds. Academic, San Diego, CA, pp. 71–102.
I Gerendai, C. Shaha, G. L. Gunsalus, and C. W. Bardin (1986) The effects of opioid receptor antagonists suggest that testicular opiates regulate sertoli and Leydig cell function in the neonatal rat.Endocrinology118, 2039–2044.
A. N. Margioris, G. Koukoulis, M. Grino, and G. P. Chrousos (1989) In vitro per-fused rat testes secrete 0-endorphin and dynorphin: their effects on testosterone secretion.Biol. Reprod.40, 776–784.
A. Fabbri (1990) The role of regulation of testicular opioids.TEMJanuary, pp. 117–120.
R. Bhanot and M. Wilkinson (1983) Opiatergic control of gonadotropin secretion during puberty in the rat: a neurochemical basis for the hypothalamic “gonadostat.”Endocrinology113, 596–603.
D. J. S. Sirinathsinghji, M. Motta, and L. Martini (1985) Induction of precocious puberty in the female rat after chronic naloxone administration during the neonatal period: the opiate “brake” on pubertal gonadotropin secretion.J. Endocrinol.104, 299–317.
R. S. Donham, E. H. Sarafidis, and M. H. Stetson (1986) Naloxone administration to female hamsters advances puberty by enhancing luteinizing hormone release.Proc. Soc. Exp. Biol. Med.182, 291–295.
C. M. Kuhn and M. Bartolome (1984) Effect of chronic methadone administration on neuroendocrine function in developing rats.Dey. Pharm. Ther.7, 384–397.
S. Iyengar, H. S. Kim, and P. L. Wood (1987) Mu, delta, kappa, and epsilon opioid receptor modulation of the hypothalamic-pituitary-adrenocortical (HPA) axis: subchronic tolerance studies of endogenous opioid peptides.Brain Res.435, 220–226.
K. H. Lookingland and K. E. Moore (1985) Differential effects of morphine on the rats of dopamine turnover in the neural and intermediate lobes of the rat pituitary gland.Life Sci.37, 1225–1229.
J. Manzanares, K. H. Lookingland, and K. E. Moore (1990) Kappa-opioid-receptor mediated regulation of a-melanocyte-stimulating hormone secretion and tuberohypophysical dopaminergic neuronal activity.Neuroendocrinologv52, 200–205.
S. Iyengar, H. S. Kim, and P. L. Wood (1986) Kappa opiate agonists modulate the hypothalamic-pituitary-adrenocortical axis in the rat.J. Pharmacol. Exp. Ther.238, 429–436.
P. Seamon, M. Titeler, and S. List (1982) Dopamine receptors in brain and pituitary, inBrain Peptides and Hormones. R. Colleu, A. Barbeau, J. R. Duchanne, and G. Titis, eds. Raven, New York, pp. 31–42.
D. M. Ignar and C. M. Kuhn (1990) Effects of specific mu and kappa opiate tolerance and abstinence on hypothalmo-pituitary-adrenal axis secretion in the rat.J. Pharmacol. Exp. Ther.255, 1287–1295.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media New York
About this chapter
Cite this chapter
Cicero, T.J., Adams, M.L. (1995). Opioid-Mediated Control of Neuroendocrine Function. In: Watson, R.R. (eds) Alcohol and Hormones. Drug and Alcohol Abuse Reviews, vol 6. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4612-0243-1_2
Download citation
DOI: https://doi.org/10.1007/978-1-4612-0243-1_2
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4612-6678-5
Online ISBN: 978-1-4612-0243-1
eBook Packages: Springer Book Archive